Response to "Three drugs are unnecessary for treating paucibacillary leprosy-A critique of the WHO guidelines".
作者信息
Kumar Bhushan, Thakur Vishal, Narang Tarun, Dogra Sunil
机构信息
Consultant Dermatologist Shalby Hospital, SAS Nagar, Punjab.
Department of Dermatology, Venereology, and Leprology; Postgraduate Institute of Medical Education and Research, Chandigarh, India.
出版信息
PLoS Negl Trop Dis. 2020 Jun 4;14(6):e0008169. doi: 10.1371/journal.pntd.0008169. eCollection 2020 Jun.
Abstract
摘要
相似文献
1
Response to "Three drugs are unnecessary for treating paucibacillary leprosy-A critique of the WHO guidelines".对《治疗少菌型麻风病无需三种药物——对世界卫生组织指南的批评》的回应
PLoS Negl Trop Dis. 2020 Jun 4;14(6):e0008169. doi: 10.1371/journal.pntd.0008169. eCollection 2020 Jun.
2
Three drugs are unnecessary for treating paucibacillary leprosy-A critique of the WHO guidelines.治疗少菌型麻风病无需三种药物——对世界卫生组织指南的批评
PLoS Negl Trop Dis. 2019 Oct 31;13(10):e0007671. doi: 10.1371/journal.pntd.0007671. eCollection 2019 Oct.
3
Clinical and histopathological features of paucibacillary leprosy before and after multidrug therapy: a prospective study.
Trans R Soc Trop Med Hyg. 2016 Jun;110(6):350-8. doi: 10.1093/trstmh/trw039. Epub 2016 Jun 17.
4
A randomized controlled trial to compare cure and relapse rate of paucibacillary multidrug therapy with monthly rifampicin, ofloxacin, and minocycline among paucibacillary leprosy patients in Agra District, India.一项随机对照试验，旨在比较印度阿格拉地区少菌型麻风病患者采用每月一次利福平、氧氟沙星和米诺环素的少菌型联合化疗的治愈率和复发率。
Indian J Dermatol Venereol Leprol. 2015 Jul-Aug;81(4):356-62. doi: 10.4103/0378-6323.159929.
5
Nerve conduction studies in paucibacillary and multibacillary leprosy: a comparative evaluation.少菌型和多菌型麻风病的神经传导研究：一项比较评估
Indian J Lepr. 2011 Jan-Mar;83(1):15-22.
6
Granulomatous abscess of the ulnar nerve in a case of paucibacillary leprosy given multidrug therapy.
Ann Trop Med Parasitol. 2010 Dec;104(8):673-4. doi: 10.1179/136485910X12851868780063.
7
Quality of life of patients with paucibacillary leprosy.少菌型麻风患者的生活质量
An Bras Dermatol. 2012 May-Jun;87(3):408-11. doi: 10.1590/s0365-05962012000300009.
8
Observations in 11 patients with leprosy and human immunodeficiency virus co-association.
Indian J Dermatol Venereol Leprol. 2011 Nov-Dec;77(6):714-6. doi: 10.4103/0378-6323.86494.
9
Comparison of quality of life evaluated by SF-36 and DLQI in multibacillary and paucibacillary leprosy patients from Sao Paulo, Brazil.巴西圣保罗的多菌型和少菌型麻风病患者的 SF-36 和 DLQI 评估的生活质量比较。
Int J Dermatol. 2019 Dec;58(12):1415-1422. doi: 10.1111/ijd.14489. Epub 2019 May 30.
10
TH17 cells, interleukin-17 and interferon-γ in patients and households contacts of leprosy with multibacillary and paucibacillary forms before and after the start of chemotherapy treatment.在开始化疗前后，多菌型和少菌型麻风患者及其家庭接触者中的 TH17 细胞、白细胞介素 17 和干扰素-γ。
J Eur Acad Dermatol Venereol. 2015 Jul;29(7):1354-61. doi: 10.1111/jdv.12869. Epub 2014 Nov 27.
引用本文的文献
1
Experiences of living with leprosy: A systematic review and qualitative evidence synthesis.麻风病患者的生活体验：系统评价和定性证据综合。
PLoS Negl Trop Dis. 2022 Oct 5;16(10):e0010761. doi: 10.1371/journal.pntd.0010761. eCollection 2022 Oct.
2
Leprosy treatment: Can we replace opinions with research?麻风病治疗：我们能否用研究取代观点？
PLoS Negl Trop Dis. 2020 Oct 8;14(10):e0008636. doi: 10.1371/journal.pntd.0008636. eCollection 2020 Oct.
本文引用的文献
1
Three drugs are unnecessary for treating paucibacillary leprosy-A critique of the WHO guidelines.治疗少菌型麻风病无需三种药物——对世界卫生组织指南的批评
PLoS Negl Trop Dis. 2019 Oct 31;13(10):e0007671. doi: 10.1371/journal.pntd.0007671. eCollection 2019 Oct.
2
A 19-Year Retrospective Study of Adverse Drug Reactions to Multidrug Therapy in Leprosy Requiring a Change in Regime.一项关于麻风病多药治疗中需改变治疗方案的药物不良反应的19年回顾性研究。
Indian Dermatol Online J. 2018 Jan-Feb;9(1):33-36. doi: 10.4103/idoj.IDOJ_116_17.
3
Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.巴西麻风病患者统一多药疗法（U-MDT/CT-BR）：多菌型患者开放标签、随机对照临床试验结果
PLoS Negl Trop Dis. 2017 Jul 13;11(7):e0005725. doi: 10.1371/journal.pntd.0005725. eCollection 2017 Jul.
4
WHO multidrug therapy for leprosy: epidemiology of default in treatment in Agra district, Uttar Pradesh, India.世界卫生组织的麻风病联合化疗：印度北方邦阿格拉地区治疗中断的流行病学情况
Biomed Res Int. 2015;2015:705804. doi: 10.1155/2015/705804. Epub 2015 Feb 1.
5
Clofazimine should be used in all cases of leprosy, says Indian research council.印度研究委员会表示，氯法齐明应用于所有麻风病病例。
BMJ. 2013 Mar 26;346:f1963. doi: 10.1136/bmj.f1963.
6
Brazilian clinical trial of uniform multidrug therapy for leprosy patients: the correlation between clinical disease types and adverse effects.巴西对麻风病患者进行统一多药物疗法的临床试验：临床疾病类型与不良反应之间的相关性。
Mem Inst Oswaldo Cruz. 2012 Dec;107 Suppl 1:74-8. doi: 10.1590/s0074-02762012000900013.
7
Six months fixed duration multidrug therapy in paucibacillary leprosy: risk of relapse and disability in Agra PB cohort study.阿格拉少菌型麻风病队列研究中六个月固定疗程多药联合治疗：复发风险与残疾情况
BMJ Open. 2012 Aug 13;2(4). doi: 10.1136/bmjopen-2012-001403. Print 2012.
8
Relapse in leprosy.麻风病复发。
Indian J Dermatol Venereol Leprol. 2009 Mar-Apr;75(2):126-35. doi: 10.4103/0378-6323.48656.
9
MDT-MB therapy in paucibacillary leprosy: a clinicopathological assessment.少菌型麻风的多药联合化疗：临床病理评估
Indian J Dermatol Venereol Leprol. 2005 Jul-Aug;71(4):242-5. doi: 10.4103/0378-6323.16614.
10
A study on trend of relapse in leprosy and factors influencing relapse.麻风病复发趋势及影响复发因素的研究。
Indian J Lepr. 2005 Apr-Jun;77(2):105-15.
Zotero 插件